Literature DB >> 11792236

Food Allergy.

John Fahrenholz1, Ronald Simon.   

Abstract

Although many emerging therapies demonstrate theoretical and practical promise, strict elimination of the allergenic food remains the only proven therapy for food hypersensitivity. Given such therapeutic limitations, accurate diagnosis and thorough patient education are critical for proper management. This is particularly important for individuals with anaphylactic potential, as food allergy is currently the single leading cause of anaphylaxis treated in hospital emergency departments.

Entities:  

Year:  2002        PMID: 11792236     DOI: 10.1007/s11938-002-0005-2

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  12 in total

1.  Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

Authors:  H Milgrom; R B Fick; J Q Su; J D Reimann; R K Bush; M L Watrous; W J Metzger
Journal:  N Engl J Med       Date:  1999-12-23       Impact factor: 91.245

2.  Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis.

Authors:  T B Casale; I L Bernstein; W W Busse; C F LaForce; D G Tinkelman; R R Stoltz; R J Dockhorn; J Reimann; J Q Su; R B Fick; D C Adelman
Journal:  J Allergy Clin Immunol       Date:  1997-07       Impact factor: 10.793

3.  Epidemiology of anaphylaxis in Olmsted County: A population-based study.

Authors:  M W Yocum; J H Butterfield; J S Klein; G W Volcheck; D R Schroeder; M D Silverstein
Journal:  J Allergy Clin Immunol       Date:  1999-08       Impact factor: 10.793

Review 4.  "Hidden" allergens in foods.

Authors:  H A Steinman
Journal:  J Allergy Clin Immunol       Date:  1996-08       Impact factor: 10.793

5.  Fatal food-induced anaphylaxis.

Authors:  J W Yunginger; K G Sweeney; W Q Sturner; L A Giannandrea; J D Teigland; M Bray; P A Benson; J A York; L Biedrzycki; D L Squillace
Journal:  JAMA       Date:  1988-09-09       Impact factor: 56.272

Review 6.  Food allergy.

Authors:  H A Sampson
Journal:  JAMA       Date:  1997-12-10       Impact factor: 56.272

7.  Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

Authors:  K Roy; H Q Mao; S K Huang; K W Leong
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

8.  Fatal and near-fatal anaphylactic reactions to food in children and adolescents.

Authors:  H A Sampson; L Mendelson; J P Rosen
Journal:  N Engl J Med       Date:  1992-08-06       Impact factor: 91.245

9.  Treatment of peanut allergy with rush immunotherapy.

Authors:  J J Oppenheimer; H S Nelson; S A Bock; F Christensen; D Y Leung
Journal:  J Allergy Clin Immunol       Date:  1992-08       Impact factor: 10.793

10.  Assessment of patients who have experienced anaphylaxis: a 3-year survey.

Authors:  M W Yocum; D A Khan
Journal:  Mayo Clin Proc       Date:  1994-01       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.